BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which...
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
Billiontoone | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 109.45 M
12 Health Care Stocks Moving In Wednesday's After-Market Session
BillionToOne Q2 FY26 net income turns to USD 8.1 million; revenue rises 64% to USD 109.4 million
BillionToOne Chief Product Officer Sakakibara Shan Riku disposes of 4,000 common shares worth $560,840
Billiontoone (NASDAQ:BLLN) Reaches New 12-Month High - Should You Buy?